Brief: Marinus Pharmaceuticals Inc Reports Q3 EPS Of $1.89
07/11/2022 21:34
Nov 7 (Reuters) - Marinus Pharmaceuticals Inc MRNS.O :
* MARINUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
THIRD QUARTER 2022 FINANCIAL RESULTS
* QTRLY TOTAL REVENUE $2.3 MILLION
* QTRLY EPS $1.89
* Q4 EARNINGS PER SHARE VIEW $-0.98, REVENUE VIEW $8.1
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nBw3qg7p0a
Further company coverage: MRNS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marinus Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Axsome Therapeutics, Ducommun, Vacasa
Brief: Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
Marinus Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Appfolio, S&P Global, Uber
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group